Earnings Feed
Start Free
Home/Insiders/Ho Peter Tai-Ching
HP
SEC Insider//CIK 0001619052

Ho Peter Tai-Ching

CIK 00016190522 companiesCAMBRIDGE, MA
SEC Profile

Transactions

47

Companies

2

Filings

9

CIK

0001619052

Recent Transactions

47 trades
  • Award
    Aravive, Inc.

    Series B Warrants (right to buy)

    2022-10-24+27,176→ 27,176 total
  • Award
    Aravive, Inc.

    Series B Warrants (right to buy)

    2022-10-24+27,176→ 27,176 total
  • Award
    Aravive, Inc.

    Series A Warrants (right to buy)

    2022-10-24+27,177→ 27,177 total
  • Award
    Aravive, Inc.

    Common stock

    2022-10-24$0.92/sh+54,353→ 55,353 total
  • Award
    Aravive, Inc.

    Series A Warrants (right to buy)

    2022-10-24+27,177→ 27,177 total
  • Award
    Aravive, Inc.

    Common stock

    2022-10-24$0.92/sh+54,353→ 55,353 total
  • Award
    Aravive, Inc.

    Stock Option (Right to Buy)

    2022-09-23+97,063→ 97,063 total
  • Award
    Aravive, Inc.

    Stock Option

    2021-09-10+22,812→ 22,812 total
  • Award
    Aravive, Inc.

    Stock Options

    2021-07-01+5,245→ 5,245 total
  • Award
    Aravive, Inc.

    Stock Options

    2021-07-01+15,435→ 15,435 total
  • Exercise/Conversion
    Epizyme, Inc.

    Stock Option (Right to Buy)

    2017-10-24−15,000→ 5,500 total
  • Sale
    Epizyme, Inc.

    Common Stock, par value $0.0001

    2017-10-24$16.44/sh−15,000→ 8,123 total
  • Exercise/Conversion
    Epizyme, Inc.

    Commons Stock, par value $0.0001

    2017-10-24$8.98/sh+15,000→ 23,123 total
  • Exercise/Conversion
    Epizyme, Inc.

    Commons Stock, par value $0.0001

    2017-09-25$8.98/sh+15,000→ 23,123 total
  • Sale
    Epizyme, Inc.

    Commons Stock, par value $0.0001

    2017-09-25$16.81/sh−15,000→ 8,123 total
  • Exercise/Conversion
    Epizyme, Inc.

    Stock Option (Right to Buy)

    2017-09-25−15,000→ 15,725 total
  • Exercise/Conversion
    Epizyme, Inc.

    Common Stock, par value $0.0001

    2017-08-24$8.98/sh+15,000→ 22,228 total
  • Sale
    Epizyme, Inc.

    Common Stock, par value $0.0001

    2017-08-24$15.68/sh−15,000→ 7,228 total
  • Exercise/Conversion
    Epizyme, Inc.

    Stock Option (Right to Buy)

    2017-08-24−15,000→ 25,950 total
  • Exercise/Conversion
    Epizyme, Inc.

    Common Stock, par value $0.0001

    2017-07-24$8.98/sh+15,000→ 22,228 total
  • Exercise/Conversion
    Epizyme, Inc.

    Stock Option (Right to Buy)

    2017-07-24−15,000→ 36,175 total
  • Sale
    Epizyme, Inc.

    Common Stock, par value $0.0001

    2017-07-24$13.44/sh−15,000→ 7,228 total
  • Exercise/Conversion
    Epizyme, Inc.

    Stock Option (Right to Buy)

    2017-06-26−15,000→ 46,400 total
  • Exercise/Conversion
    Epizyme, Inc.

    Commons Stock, par value $0.0001

    2017-06-26$8.98/sh+15,000→ 22,228 total
  • Sale
    Epizyme, Inc.

    Commons Stock, par value $0.0001

    2017-06-26$14.87/sh−15,000→ 7,228 total
  • Exercise/Conversion
    Epizyme, Inc.

    Stock Option (Right to Buy)

    2017-05-25−15,000→ 56,625 total
  • Exercise/Conversion
    Epizyme, Inc.

    Common stock, par value $0.0001

    2017-05-25$8.98/sh+15,000→ 22,228 total
  • Sale
    Epizyme, Inc.

    Commons Stock, par value $0.0001

    2017-05-25$16.11/sh−15,000→ 7,228 total
  • Award
    Epizyme, Inc.

    Common stock, par value $0.0001

    2017-02-28$6.21/sh+1,708→ 7,228 total
  • Award
    Epizyme, Inc.

    Stock Option (Right to Buy)

    2017-02-08+122,074→ 122,074 total
  • Sale
    Epizyme, Inc.

    Common stock, par value $0.0001

    2016-12-08$10.89/sh−200→ 5,520 total
  • Award
    Epizyme, Inc.

    Common Stock, par value $0.0001

    2016-08-31$6.21/sh+1,362→ 5,720 total
  • Purchase
    Epizyme, Inc.

    Common Stock, par value $0.0001 per share

    2016-02-29$7.47/sh+636→ 5,358 total
  • Award
    Epizyme, Inc.

    Stock Option (Right to Buy)

    2016-02-08+229,200→ 229,200 total
  • Purchase
    Epizyme, Inc.

    Common Stock, par value $0.0001 per share

    2015-12-09$14.69/sh+1,000→ 4,722 total
  • Purchase
    Epizyme, Inc.

    Common Stock, par value $0.0001 per share

    2015-08-31$17.00/sh+522→ 3,522 total
  • Purchase
    Epizyme, Inc.

    Common Stock, par value $0.0001 per share

    2015-08-20$16.51/sh+2,000→ 3,000 total
  • Purchase
    Epizyme, Inc.

    Common Stock, par value $0.0001 per share

    2015-08-20$16.51/sh+2,000→ 2,200 total
  • Purchase
    Epizyme, Inc.

    Common Stock, par value $0.0001 per share

    2015-05-05$16.36/sh+400→ 1,000 total
  • Purchase
    Epizyme, Inc.

    Common Stock, par value $0.0001 per share

    2015-05-05$16.36/sh+400→ 1,000 total
  • Award
    Epizyme, Inc.

    Stock Option (Right to Buy)

    2015-02-13+35,778→ 35,778 total
  • Purchase
    Epizyme, Inc.

    Common Stock, par value $0.0001 per share

    2014-12-16$17.63/sh+200→ 600 total
  • Purchase
    Epizyme, Inc.

    Common Stock, par value $0.0001 per share

    2014-12-16$17.63/sh+200→ 600 total
  • Purchase
    Epizyme, Inc.

    Common Stock, par value $0.0001 per share

    2014-12-02$21.19/sh+200→ 200 total
  • Purchase
    Epizyme, Inc.

    Common Stock, par value $0.0001 per share

    2014-12-02$21.16/sh+400→ 400 total
  • Purchase
    Epizyme, Inc.

    Common Stock, par value $0.0001 per share

    2014-12-02$21.16/sh+400→ 400 total
  • Award
    Epizyme, Inc.

    Stock Option (Right to Buy)

    2014-09-11+150,000→ 150,000 total

Companies

2

Recent Filings

9

Address

C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE

CAMBRIDGE, MA, 02139

View on SEC.gov